393: A conversation with the 'godfather' of biotech
About this episode
This episode features a conversation with Stelios Papadapolous, the 'godfather' of biotech, discussing recent developments in the industry.
On this week's episode of "The Readout LOUD," we bring you a special conversation with Stelios Papadapolous, also know as the "godfather" of biotech. He sat down for an on-stage chat with our colleague Damian Garde Thursday afternoon during STAT’s Breakthrough Summit East event in New York City. We also chat about the latest biotech news, including new weight loss data from Structure Therapeutics and Eli Lilly, plus recent staff departures from the Food and Drug Administration.
People in this episode
Host: Damian Garde
Guest: Stelios Papadapolous
Topics covered
- biotech
- weight loss
- FDA
- biotech news
- interview
Keywords
- biotech
- Stelios Papadapolous
- weight loss
- FDA
- Structure Therapeutics
- Eli Lilly
Mentioned in this episode
Organizations: Structure Therapeutics, Eli Lilly, Food and Drug Administration
Places: New York City
More episodes of The Readout Loud
- 398: A CAR-T biotech's dramatic turnaround, and drugmakers' tactics to drive more scripts
- 397: A pancreatic cancer breakthrough, and new hope for an off-the-shelf CAR-T treatment
- 396: A new trick for old science, and biotech VCs' scrambled playbook
- 395: Biotech investors' plea to Trump, and a busy M&A week
- 394: Eli Lilly's deal man, Allogene's off-the-shelf CAR-T, and Merck's Terns buy
- 392: Epstein's pal attempts a biotech comeback, and Prasad exits the FDA
Explore listener stats, chart rankings, contacts and more on the The Readout Loud podcast page.